Efficacy and safety of combination therapy with interferon and immunomodulators in entecavir-suppressed chronic hepatitis B patients (the endeavor study)
第一作者单位:[1]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Dept & Inst Infect Dis,Wuhan,Hubei,Peoples R China
推荐引用方式(GB/T 7714):
Wu D.,Wang P.,Han M.,et al.Efficacy and safety of combination therapy with interferon and immunomodulators in entecavir-suppressed chronic hepatitis B patients (the endeavor study)[J].JOURNAL OF HEPATOLOGY.2018,68:S509-S509.doi:10.1016/S0168-8278(18)31265-0.
APA:
Wu, D.,Wang, P.,Han, M.,Chen, Y.,Chen, X. -Y....&Ning, Q..(2018).Efficacy and safety of combination therapy with interferon and immunomodulators in entecavir-suppressed chronic hepatitis B patients (the endeavor study).JOURNAL OF HEPATOLOGY,68,
MLA:
Wu, D.,et al."Efficacy and safety of combination therapy with interferon and immunomodulators in entecavir-suppressed chronic hepatitis B patients (the endeavor study)".JOURNAL OF HEPATOLOGY 68.(2018):S509-S509